Frequency: 4 weeks
Sponsors
Intas Pharmaceuticals Ltd
Conditions
Health Condition 1: C569- Malignant neoplasm of unspecifiedovary
Unknown Phase
A comparative study of Doxorubicin Hydrochloride (Pegylated Liposomal) in patients with a cancer of female organs that produce eggs
Active, not recruitingCTRI/2018/01/011498
Target: 66Updated: 2021-11-24
A comparative study of Doxorubicin Hydrochloride Liposome Injection 20 mg/10 mL (2 mg/mL) in patients with a cancer of female organs that produce eggs
RecruitingCTRI/2018/01/011550
Target: 66Updated: 2021-11-24